• Medical device maker Masimo is confident it can win its legal battle against Apple over a feature on the Apple Watch, citing previous victories against True Wearables, a startup run by a former Apple executive.
• Masimo alleges that Apple couldn’t have developed certain watch technologies without the help of Marcelo Lamego, who previously worked at both Masimo and Apple.
• Masimo CEO Joe Kiani accuses Apple of a deliberate infringement of intellectual property, resulting in an import ban on certain Apple Watch models, which has been temporarily paused pending further review.
This is the best summary I could come up with:
And there’s a good reason Masimo might believe that: the company came out on top when it sued True Wearables, a startup run by a former executive with a stint on the Apple Watch team, on similar grounds.
Well, the pulse oximeter tech isn’t the only parallel between Masimo’s cases against True Wearables and Apple: before starting True Wearables, founder and CEO Marcelo Lamego worked at both Masimo and Apple, where he helped develop similar technologies.
He also worked closely with the team that developed non-invasive sensors and monitors for vitals like blood oxygen levels.
However, as pointed out by Bloomberg, Lamego left Apple mere months after joining because he “clashed with managers, demanded multimillion-dollar budgets and wanted the ability to hire his own engineers without approval.” That’s when Lamego went on to start his own company, True Wearables, which Masimo claimed used its technology when developing the Oxxiom, a wireless and disposable pulse oximeter.
One of those employees is former Masimo executive Michael O’Reilly, who started at Apple in 2013 and currently works on the company’s Health Special Projects team, according to his LinkedIn profile.
One year after its win against True Wearables, Masimo CEO Joe Kiani is turning up the heat on Apple.
The original article contains 886 words, the summary contains 205 words. Saved 77%. I’m a bot and I’m open source!